EDITORIAL
Published on 04 Jan 2023
Editorial: Aldehyde dehydrogenase in clinical settings: Potential biomarker and therapeutic target in solid tumors
doi 10.3389/fmed.2022.1116908
- 695 views
- Frontiers in Medicine
- Pathology
- Research Topics
- Aldehyde Dehydrogenase in Clinical Settings: Potential Biomarker and Therapeutic Target in Solid Tumors
Aldehyde Dehydrogenase in Clinical Settings: Potential Biomarker and Therapeutic Target in Solid Tumors
6,905
Total downloads
22k
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
REVIEW
Published on 28 Oct 2022
ALDH1: A potential therapeutic target for cancer stem cells in solid tumors
doi 10.3389/fonc.2022.1026278
- 8,268 views
- 40 citations
CASE REPORT
Published on 28 Jun 2022
Sclerosing Epithelioid Fibrosarcoma of the Thoracic Vertebrae: An Fairly Unusual Case Report With a Short Review of Literature
doi 10.3389/fmed.2022.833864
- 2,151 views
- 4 citations
ORIGINAL RESEARCH
Published on 02 Mar 2022
NLRP6-Dependent Pyroptosis-Related lncRNAs Predict the Prognosis of Hepatocellular Carcinoma
doi 10.3389/fmed.2022.760722
- 2,048 views
- 5 citations
MINI REVIEW
Published on 01 Mar 2022
Emerging Roles of Aldehyde Dehydrogenase Isoforms in Anti-cancer Therapy Resistance
doi 10.3389/fmed.2022.795762
- 7,162 views
- 36 citations
Published in
Frontiers in Medicine
- Pathology
- Translational Medicine
Impact
- 22kTopic views
- 14kArticle views
- 6,905Article downloads